Literature DB >> 11923476

Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity.

Alexander Oksche1, Gabriele Leder, Susanne Valet, Matthias Platzer, Kerstin Hasse, Soeren Geist, Gerd Krause, André Rosenthal, Walter Rosenthal.   

Abstract

Cloning and sequencing of the murine chromosomal region XB harboring the murine vasopressin V(2) receptor (mV(2)R) gene and comparison with the orthologous human Xq28 region harboring the human vasopressin V(2) receptor (hV(2)R) revealed conservation of the genomic organization and a high degree of sequence identity in the V(2)R coding regions. Despite an identity of 87% of the amino acid sequences, both receptors show marked functional differences upon stable expression in Chinese hamster ovary cells: the mV(2)R displayed a 5-fold higher affinity for [(3)H]AVP than the human ortholog; similar differences were found for the AVP-mediated activation of adenylyl cyclase. Saturation binding experiments with transiently transfected intact COS.M6 cells showed that the mV(2)R was 3- to 5-fold less abundantly expressed at the cell surface than the hV(2)R. Laser scanning microscopy of fusion proteins consisting of the V(2)Rs and green fluorescent protein (GFP) (mV(2)R/GFP, hV(2)R/GFP) demonstrated that the hV(2)R/GFP was efficiently transported to the plasma membrane, whereas the mV(2)R/GFP was localized mainly within the endoplasmic reticulum. Chimeric hV(2)Rs, in which the first and/or second extracellular loop(s) were replaced by the corresponding loop(s) of the mV(2)R, revealed that the second extracellular loop accounts for the differences in ligand binding, but the first extracellular loop accounts for the reduced cell surface expression. The exchange of lysine 100 by aspartate in the first extracellular loop of hV(2)R was sufficient to reduce cell surface expression, which was accompanied by intracellular retention as observed in laser scanning microscopy analysis. Conversely, the exchange of aspartate 100 by lysine in the mV(2)R increased the cell surface expression and resulted in predominant plasma membrane localization. Thus, a single amino acid difference in the first extracellular loop between mV(2)R and hV(2)R determines the efficiency of cell surface expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923476     DOI: 10.1210/mend.16.4.0796

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  6 in total

Review 1.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

2.  Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand.

Authors:  Sylvia Chen; Matthew J Webber; Jean-Pierre Vilardaga; Ashok Khatri; Dennis Brown; Dennis A Ausiello; Herbert Y Lin; Richard Bouley
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736

Review 3.  The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors.

Authors:  Slawomir Filipek; David C Teller; Krzysztof Palczewski; Ronald Stenkamp
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-02-05

4.  Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus.

Authors:  Frédéric Jean-Alphonse; Sanja Perkovska; Marie-Céline Frantz; Thierry Durroux; Catherine Méjean; Denis Morin; Stéphanie Loison; Dominique Bonnet; Marcel Hibert; Bernard Mouillac; Christiane Mendre
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

5.  Study of V2 vasopressin receptor hormone binding site using in silico methods.

Authors:  Yeganeh Sebti; Soroush Sardari; Hamid Mir Mohammad Sadeghi; Mohammad Hossein Ghahremani; Giulio Innamorati
Journal:  Res Pharm Sci       Date:  2015 Jul-Aug

6.  Effect of mutations in putative hormone binding sites on V2 vasopressin receptor function.

Authors:  Y Sebti; M Rabbani; H Mir Mohammad Sadeghi; S Sardari; M H Ghahremani; G Innamorati
Journal:  Res Pharm Sci       Date:  2015 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.